From Priming to Therapy: Leveraging New Insights in T Cell Activation
Immune Discovery · 2025
DOI: 10.70322/immune.2025.10012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immune Discovery, 2025. Verfasst von Katarzyna Jobin und 2 weiteren Autor:innen. Die Arbeit nennt 116 Literaturangaben.
Abstract (Originalsprache)
CD8 T cells constitute one of the pillars of the adaptive immune response. They play a key role in eliminating pathogen-infected and cancerous cells. To effectively carry out their function, naïve CD8 T cells must undergo priming/activation in which several cell types, receptors, cytokines, and chemokines are involved. Various therapeutic approaches, such as vaccinations and anti-cancer therapies, i.e., immune checkpoint blockade (ICB) and Chimeric Antigen Receptor (CAR) T cell transfer, attempt to harness CD8 T cell biology to protect from or treat life-threatening diseases. Despite the significant success of CD8-T-cell-related therapies, the overall response rate of cancer patients remains relatively low, perhaps due to an incomplete understanding of the crucial events leading to optimal CD8 T cell activation. Recent findings highlight the importance of CD4 T cell help in CD8 T cell priming as well as the existence of an additional priming phase for the selection and expansion of high affinity T cells. Together, these findings offer a refined conceptual framework to guide future research and therapeutic development. Here, we present a revised perspective on clinically relevant CD8 T cell–based therapies in light of recent discoveries.
Zitieren
APA
Jobin, K., Seetharama, D., & Kastenm黮ler, W. (2025). From Priming to Therapy: Leveraging New Insights in T Cell Activation. Immune Discovery. https://doi.org/10.70322/immune.2025.10012
Vancouver
Jobin K, Seetharama D, Kastenm黮ler W. From Priming to Therapy: Leveraging New Insights in T Cell Activation. Immune Discovery. 2025. doi:10.70322/immune.2025.10012
BibTeX
@article{Jobin2025,
author = {Jobin, Katarzyna and Seetharama, Deeksha and Kastenm黮ler, Wolfgang},
title = {From Priming to Therapy: Leveraging New Insights in T Cell Activation},
journal = {Immune Discovery},
year = {2025},
doi = {10.70322/immune.2025.10012}
}
EUVIMED